Sign up to save your podcasts
Or
Share Q3 earnings recap: Winners, losers & surprises
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Q3 earnings recap: Winners, losers & surprises
This week (our inaugural episode!) BioSpace's Greg Slabodkin, Tyler Patchen and Lori Ellis discuss the good, the bad and the ugly of biopharma's reported Q3 earnings. They also tackle what's going on at Pfizer, ADCs, deals and more.
Want to dive deeper on BioSpace? Read more on Pfizer's recent cuts as part of their cost-savings program and more insight on Q3 earnings for Gilead, Novo Nordisk, Moderna, Vertex, BMS, Lilly, GSK.
Meanwhile, industry-wide layoffs march on and in case you missed it - bankruptcies reached a record high.
View all episodes
By BioSpace
4.9
1313 ratings
This week (our inaugural episode!) BioSpace's Greg Slabodkin, Tyler Patchen and Lori Ellis discuss the good, the bad and the ugly of biopharma's reported Q3 earnings. They also tackle what's going on at Pfizer, ADCs, deals and more.
Want to dive deeper on BioSpace? Read more on Pfizer's recent cuts as part of their cost-savings program and more insight on Q3 earnings for Gilead, Novo Nordisk, Moderna, Vertex, BMS, Lilly, GSK.
Meanwhile, industry-wide layoffs march on and in case you missed it - bankruptcies reached a record high.
More shows like BioSpace
View all
This American Life
90,994 Listeners
Planet Money
30,666 Listeners
Hidden Brain
43,528 Listeners
Marketplace
8,776 Listeners
Exchanges
970 Listeners
WSJ What’s News
4,345 Listeners
Bloomberg Surveillance
1,170 Listeners
Odd Lots
1,967 Listeners
Up First from NPR
56,508 Listeners
The Indicator from Planet Money
9,532 Listeners
The Readout Loud
337 Listeners
The Journal.
6,089 Listeners
Short Wave
6,564 Listeners
BioCentury This Week
34 Listeners
Biotech Hangout
23 Listeners